CELL PATHWAYS INC /DE
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Item 5 · Item 7Feb 12, 2003
- Item 4 · Item 7Jun 18, 2002
- Item 5Sep 29, 2000
- Item 5 · Item 7Sep 28, 1999
- Item 5 · Item 7Dec 18, 1998
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15Jun 12, 2003
- 425INFORMATION RE: MERGERMay 30, 2003
- 425FILED PURSUANT TO RULE 425May 14, 2003
- 425FORM 425 FOR CELL PATHWAYS, INC.May 14, 2003
- 10-QFORM 10-Q FOR THE QUARTERLY PERIOD ENDED 3/31/2003May 14, 2003
- DEFM14ADEFINITIVE PROXY MATERIALSMay 7, 2003
- 10-KFORM 10-K CELL PATHWAYS, INC.Mar 27, 2003
- 425OSI PHARMACEUTICALS, INC.Mar 12, 2003
- 425CELL PATHWAYS, INC. FORM 425 FILINGMar 6, 2003
- 425OSI PHARMACEUTICALS, INC.Mar 5, 2003
- SC 13G/AGET OUT - GRANDFATHERED - MSFeb 13, 2003
- 425CELL PATHWAYS, INC. FORM 425Feb 12, 2003
- 8-KFORM 8-K DATED FEBRUARY 7, 2003Feb 12, 2003
- 425FILED PURSUANT TO RULE 425Feb 11, 2003
- 425CELL PATHWAYS, INC./OSI PHARMACEUTICALS, INC.Feb 10, 2003
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.